Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy
Articolo
Data di Pubblicazione:
2015
Citazione:
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy / Montagna, E.; Bagnardi, V.; Viale, G.; Rotmensz, N.; Sporchia, A.; Cancello, G.; Balduzzi, A.; Galimberti, V.; Veronesi, P.; Luini, A.; Mastropasqua, M. G.; Casadio, C.; Sangalli, C.; Goldhirsch, A.; Colleoni, M.. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 26:2(2015), pp. 307-313. [10.1093/annonc/mdu528]
Abstract:
We collected information on 904 consecutive breast cancer patients treated with neoadjuvant chemotherapy at the European Institute of Oncology, Milan, Italy, between 1999 and 2011. The decrease of PgR and Ki-67 expression after preoperative chemotherapy has a prognostic role in breast cancer patients with residual disease.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Breast cancer; Chemotherapy; HER2; Hormonal receptors; Neoadjuvant therapy; Surgery; Adult; Aged; Biomarkers; Tumor; Breast Neoplasms; Chemotherapy; Adjuvant; Disease-Free Survival; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Ki-67 Antigen; Middle Aged; Neoadjuvant Therapy; Neoplasm; Residual; Prognosis; Proportional Hazards Models; Receptors; Estrogen; Receptors; Progesterone; Retrospective Studies; Treatment Outcome
Elenco autori:
Montagna, E.; Bagnardi, V.; Viale, G.; Rotmensz, N.; Sporchia, A.; Cancello, G.; Balduzzi, A.; Galimberti, V.; Veronesi, P.; Luini, A.; Mastropasqua, M. G.; Casadio, C.; Sangalli, C.; Goldhirsch, A.; Colleoni, M.
Link alla scheda completa:
Pubblicato in: